Clinical Trial Update: Study of Safety and Biomarker Efficacy of TS23 in Healthy Volunteer [Phase 1]

View source ↗

Summary

Phase 1 trial update assessing safety and biomarker efficacy of TS23 in healthy volunteers, with relevance to thrombosis and ischemia-related conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Ischemia
• Myocardial Infarction
• Pulmonary Embolism
• Thrombosis
• Venous Thrombosis

Drugs mentioned

• TS23

Snippet

Sponsor: Translational Sciences, Inc. | Conditions: Thrombosis, Cerebral Ischemia | Phase 1 | Status: UNKNOWN